MNKD and SCPH Related Headlines
Go Back- MannKind completes scPharmaceuticals acquisition for $6.35 per share
- MannKind to acquire scPharmaceuticals for up to $360 million
- MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

